AML Treatment in Untreated Adult Patients

NCT00449319 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Leukemia, Myelocytic, Acute

Interventions

PROCEDURE: Identification of appropriate therapies according to risks factors
DRUG: Daunorubicine
PROCEDURE: Transplant

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto